Skip to search formSkip to main contentSkip to account menu

KP 136

Known as: 2H-1-Benzopyran-2-one, 8-(hexyloxy)-3-(1H-tetrazol-5-yl)-, KP-136 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ChromonesTetrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
[Effect of KP-136 on allergic paw edema in the rat].
The pharmacological properties of KP-136, an inhibitor of type I allergy, were studied in rat paw models. In four allergic… 
1989
1989
Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid.
Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-buty ric acid (C4C) were studied. C4C is an active… 
1989
1989
Effect of 8-hexyloxy-3-(1H-tetrazol-5-yl)-2H-chromen-2-one [KP-136] on experimental asthma: a comparison with disodium cromoglycate.
The pharmacological properties of 8-hexyloxy-3-(1H-tetrazol-5-yl)-2H-chromen-2-one, KP-136 were compared with those of an… 
1988
1988
The protective effect of a new antiallergic agent, KP-136 on mast cell activation: A comparison with disodium cromoglycate
The protective effects on mast cell activation were compared between a new antiallergic agent, KP-136 and disodium cromoglycate… 
1987
1987
[The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models].
The pharmacological properties of KP-136 were studied using cutaneous reactions in rats and guinea pigs. KP-136 remarkably… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)